Sigma Investment Counselors Inc. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 0.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,321 shares of the medical equipment provider's stock after buying an additional 93 shares during the quarter. Sigma Investment Counselors Inc.'s holdings in Intuitive Surgical were worth $3,677,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also made changes to their positions in the stock. HB Wealth Management LLC grew its position in shares of Intuitive Surgical by 35.7% during the second quarter. HB Wealth Management LLC now owns 1,909 shares of the medical equipment provider's stock worth $383,000 after buying an additional 502 shares in the last quarter. Cordasco Financial Network boosted its holdings in Intuitive Surgical by 6.9% in the second quarter. Cordasco Financial Network now owns 1,540 shares of the medical equipment provider's stock worth $309,000 after purchasing an additional 100 shares during the period. IFM Investors Pty Ltd boosted its holdings in Intuitive Surgical by 4.0% in the second quarter. IFM Investors Pty Ltd now owns 62,579 shares of the medical equipment provider's stock worth $12,560,000 after purchasing an additional 2,391 shares during the period. Tompkins Financial Corp boosted its holdings in Intuitive Surgical by 5.5% in the second quarter. Tompkins Financial Corp now owns 14,830 shares of the medical equipment provider's stock worth $2,976,000 after purchasing an additional 773 shares during the period. Finally, Gofen & Glossberg LLC IL boosted its holdings in Intuitive Surgical by 72.4% in the second quarter. Gofen & Glossberg LLC IL now owns 23,044 shares of the medical equipment provider's stock worth $4,625,000 after purchasing an additional 9,676 shares during the period. Institutional investors and hedge funds own 82.44% of the company's stock.
Get Intuitive Surgical alerts:Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction dated Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the transaction, the director now owns 11,224 shares of the company's stock, valued at approximately $2,671,760.96. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CEO Gary S. Guthart sold 79,412 shares of the business's stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $216.30, for a total value of $17,176,815.60. Following the completion of the sale, the chief executive officer now directly owns 54,607 shares in the company, valued at approximately $11,811,494.10. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total value of $1,517,505.00. Following the completion of the sale, the director now owns 11,224 shares of the company's stock, valued at $2,671,760.96. The disclosure for this sale can be found here. Insiders have sold a total of 101,162 shares of company stock valued at $22,062,916 in the last 90 days. 0.90% of the stock is currently owned by corporate insiders.
Intuitive Surgical Stock Performance
ISRG traded down $1.77 during trading on Friday, reaching $189.31. The company had a trading volume of 32,420 shares, compared to its average volume of 1,720,567. The firm's 50-day simple moving average is $219.31 and its 200 day simple moving average is $233.72. The company has a market cap of $67.60 billion, a price-to-earnings ratio of 48.62, a PEG ratio of 5.43 and a beta of 1.31. Intuitive Surgical, Inc. has a 12-month low of $186.83 and a 12-month high of $369.69.Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share for the quarter, missing the consensus estimate of $1.04 by ($0.19). Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. The business had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period last year, the firm earned $1.42 EPS. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 3.76 EPS for the current year.
Analyst Ratings Changes
ISRG has been the subject of a number of research reports. The Goldman Sachs Group decreased their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating for the company in a report on Friday, July 29th. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $250.00 to $260.00 and gave the company a "buy" rating in a report on Friday, September 9th. Raymond James reduced their price target on shares of Intuitive Surgical from $294.00 to $255.00 in a report on Friday, July 22nd. Evercore ISI reduced their price target on shares of Intuitive Surgical from $210.00 to $175.00 in a report on Friday, July 22nd. Finally, Piper Sandler boosted their price target on shares of Intuitive Surgical from $255.00 to $260.00 and gave the company an "overweight" rating in a report on Thursday, August 18th. Six equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $268.00.
About Intuitive Surgical
(Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.